• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Osiris Therapeutics Inc.

Smith & Nephew closes Osiris Therapeutics, Leaf Healthcare buys

April 17, 2019 By Fink Densford

Smith & Nephew (NYSE:SNN) said today that it closed both its $660 million acquisition of Osiris Therapeutics (NSDQ:OSIR) and its purchase of Leaf Healthcare and its Leaf Patient Monitoring System. The London-based company said that it paid $19 per share in cash for Osiris, which develops and produces regenerative medicine products including skin, bone grafts and articular […]

Filed Under: Business/Financial News, Featured, Mergers & Acquisitions, Patient Monitoring, Regenerative Medicine, Wall Street Beat Tagged With: Leaf Healthcare, Osiris Therapeutics Inc., Smith & Nephew

Osiris shareholders sue to block $660m merger with Smith & Nephew

March 27, 2019 By Brad Perriello

A group of Osiris Therapeutics (NSDQ:OSIR) shareholders is suing to block its $660 million acquisition by Smith & Nephew (NYSE:SNN) because the purchase price is too low. Earlier this month the British orthopedics and wound care giant put $19 per share on the table to acquire Osiris and its regenerative medicine portfolio, representing a 37% premium on the 90-day […]

Filed Under: Featured, Legal News, Mergers & Acquisitions, Regenerative Medicine, Wall Street Beat Tagged With: Osiris Therapeutics Inc., Smith & Nephew

Smith & Nephew puts up $660m for Osiris Therapeutics

March 12, 2019 By Brad Perriello

Smith & Nephew (NYSE:SNN) said today that it agreed to put $660 million on the table to acquire Osiris Therapeutics (NSDQ:OSIR) and its regenerative medicine portfolio. The British orthopedics and wound care giant said the $19-per-share deal is a 37% premium on the 90-day volume-weighted average for OSIR shares. It’s structured as a two-step tender […]

Filed Under: Featured, Mergers & Acquisitions, Regenerative Medicine, Wall Street Beat Tagged With: Osiris Therapeutics Inc., Smith & Nephew

MiMedx escapes Osiris trade theft suit

December 14, 2018 By Brad Perriello

MiMedx (NSDQ:MDXG) enjoyed a rare spot of good news when a federal judge in Maryland this week dismissed a trade theft and breach-of-contract lawsuit brought by Osiris Therapeutics over MiMedx’s  Stability Biologics acquisition. Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after […]

Filed Under: Legal News, Regenerative Medicine Tagged With: MiMedx Group Inc., Osiris Therapeutics Inc.

Osiris levels $7m trade theft, breach-of-contract suit against MiMedx over Stability Biologics deal

April 5, 2018 By Brad Perriello

Osiris Therapeutics leveled trade theft and breach-of-contract charges worth nearly $7 million against a regenerative medicine rival, stemming from the Stability Biologics acquisition by MiMedx (NSDQ:MDXG). Columbia, Md.-based Osiris said it inked a distribution deal back in 2013 to have Stability sell a pair of its products through the end of 2015. But after MiMedx paid $10 million for […]

Filed Under: Legal News, Regenerative Medicine Tagged With: MiMedx Group Inc., Osiris Therapeutics Inc., Stability Biologics

Osiris wins positive review from BCBSA for Grafix

March 17, 2016 By Fink Densford

Osiris Therapeutics said today the Blue Cross Blue Shield Association gave the company’s Grafix a positive review when used to treat individuals with diabetic lower-extremity ulcers. Gravix is a cryopreserved placental membrane designed as a wound cover for patients with chronic wounds, and can conform and be applied directly to acute and chronic wounds, the company […]

Filed Under: Business/Financial News, Regenerative Medicine Tagged With: Osiris Therapeutics Inc.

Ex-Monarch Medical CEO Wilson lands at Nihon Kohden | Personnel Moves

April 15, 2015 By Brad Perriello

Ex-Monarch Medical CEO Wilson lands at Nihon Kohden | Personnel Moves

Filed Under: News Well Tagged With: CryoLife, Monarch Medical, Nihon Kohden, Osiris Therapeutics Inc., Personnel Moves, STAAR Surgical Co

Stryker debuts Osiris bone putty

March 27, 2015 By Mark Hollmer Leave a Comment

Stryker debuts Osiris bone putty

Filed Under: News Well, Orthopedics, Regenerative Medicine Tagged With: American Academy of Orthopedic Surgeons (AAOS), Osiris Therapeutics Inc., Resorbable bone materials, Stryker

Osiris strikes deal with Stryker for bone-repair product

January 5, 2015 By Val Kennedy Leave a Comment

Osiris strikes deal with Stryker for bone-repair product

Osiris Therapeutics said it struck an exclusive marketing deal with Stryker (NYSE:SYK) for its Bio4 bone allograft.

Filed Under: News Well, Orthopedics, Regenerative Medicine Tagged With: Osiris Therapeutics Inc., Stryker

Acelity snares Smith & Nephew exec Agarwal | Personnel Moves

December 9, 2014 By Brad Perriello Leave a Comment

Acelity snares Smith & Nephew exec Agarwal | Personnel Moves

Filed Under: News Well Tagged With: Acelity, Agilent Technologies Inc., ConMed Corp., GI Dynamics, OMNIlife Science Inc., Osiris Therapeutics Inc., Personnel Moves, stericycle, SynGen, Tal Medical

Stryker taps new medical chief

January 9, 2013 By MassDevice staff Leave a Comment

Stryker

Stryker (NYSE:SYK) tapped Dr. Scott Bruder, a Becton Dickinson & Co. (NYSE:BDX) veteran, to fill its newly created chief medical & scientific officer position.

Filed Under: News Well Tagged With: Anika Therapeutics Inc., becton dickinson, Johnson and Johnson, Osiris Therapeutics Inc., Personnel Moves, Stryker

  • Go to page 1
  • Go to page 2
  • Go to Next Page »

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS